Navigation Links
UTMB inventions win University of Texas System commercialization awards
Date:4/18/2008

GALVESTON, Texas Two inventions created by University of Texas Medical Branch at Galveston researchers have won $50,000 awards from the Texas Ignition Fund, a new program designed to spur the commercialization of technologies developed at UT System institutions.

One of the inventions, conceived by UTMB anesthesiology professor George Kramer, is a new smart IV pump to deliver precise amounts of fluids to trauma and burn victims. The device is lighter and less expensive than current IV pumps. In combination with newly developed patient-monitoring and computerized autonomous care systems, it has the potential to extend the sort of expert fluid therapy normally found only in hospitals to emergency medical services, combat trauma care and disasters involving large numbers of casualties.

The other UTMB TIF-award winner, a collaboration between technician Edward Kraft, instructor Stephen L. Hoskins and Dr. Perenlei Enkhbaatar (also members of UTMBs anesthesiology department), is a new technology meant to dramatically improve the delivery of inhaled drugs, such as those found in asthma inhalers. This dry powder pulmonary drug delivery system is aimed especially at emergency drug treatment of heart attacks and toxic gas exposure.

UTMB is proud that both of our submissions to the TIF were chosen for funding, and were grateful that the UT System is going to help us bring them into the commercial arena, said James Arie, UTMBs assistant vice president for technology development.

Overall, the Texas Ignition Fund awarded $465,000 to 14 different proposals from UT System researchers at a variety of different institutions. The grants range from $10,000 to $50,000 each, and are drawn from a $2 million fund approved by the UT System Board of Regents in December 2007.

We are pleased with the quality of these first proposals for Texas Ignition Fund grants and delighted that the availability of the grants has spurred so much interest o
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. University of Arizona scientist shares in discovery of microbe filaments power
2. Flowers fragrance diminished by air pollution, University of Virginia study indicates
3. Pitt and University of Chicago researchers uncover process behind heart muscle contraction
4. Yale Universitys Strobel recognized for work on RNA
5. Womens health-related scientific findings presented by University of Pittsburgh researchers
6. Researchers at Stockholm University awarded the Descartes prize
7. Policing cells demand ID to tell friend from foe, say University of Pennsylvania cell engineers
8. Antarcticas coldest, darkest season draws Montana State University researchers
9. University of Colorado at Boulder awarded $1 million for biofuels research
10. Viruses evolve to play by host rules, according to University of Pennsylvania researchers
11. New whitepaper offers options for university implementation of NIH policy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...gy Research Center (ERC) has been awarded a grant ...p methods of recovering and reusing the heat that ...ompression process in a carbon capture system. The...bon capture and sequestration, or storage (CCS), a...s, emitted into the atmosphere by coal-fired power...
(Date:11/19/2009)...ng brain chemical with an unwieldy name: 4-hydroxy...or used as a date-rape drug. , Now, a team of O...utes by which 4-HB is metabolized by the body. "Th...ael Gibson, professor and chair of biological scie...mber of the research team. "It may provide new cl...
(Date:11/19/2009)...s, which cultivate fungus for food, have many rema...the list: the ant farmers, like their human counte... their gardens grow. The finding, reported this we... previously unknown symbiosis between ants and bac...ts have come to dominate the American tropics and ...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2No Votes on Health Care Bill Received 242 3 Million More from Health Insurance Industry 60990 1No Votes on Health Care Bill Received 242 3 Million More from Health Insurance Industry 60990 2PETCO Stores Nationwide Host Pet Nutrition Workshops 60988 1Haft Group says Bullish Commodity Market Triggers Small and Micro cap Upsurge 14769 1Haft Group says Bullish Commodity Market Triggers Small and Micro cap Upsurge 14769 2
... unusual intersection of materials science and ant... of Standards and Technology (NIST) and The George...s-science-based mathematical models to help shed l...historic relatives. Their work forms part of a new...arly hominid Australopithecus africanus by anthrop...
...entity and origin of tiny, potentially hazardous p...een revealed by a new study at Queensland Universi...m QUT,s International Laboratory for Air Quality a...d by earlier findings that almost one third of pop...fine particles. , These tiny particles are potent...
...X, Ariz. Feb. 11, 2009 The Van Andel Research In...arch Institute (TGen) will forge a strategic allia...ide contributions to science and health. , The no...oday the initiation of an "alliance and affiliatio...pids, Mich.-based VARI and Phoenix, Ariz.-based TG...
Other Biology News:Toothsome research: Deducing the diet of a prehistoric hominid 2Van Andel Research Institute and TGen undertake alliance to promote science and health 2Van Andel Research Institute and TGen undertake alliance to promote science and health 3
(Date:11/20/2009)...s have an opportunity to take the lead in two smal...ersity of Valencia (UV), working together with the...abric of the Spanish biotechnology industry. Their... have more clout than those in English-speaking co...plants has been overlooked by the leading countrie...
(Date:11/20/2009)...Newswire-FirstCall/ -- Cell Therapeutics, Inc. (CT... Ninth Circuit Court of Appeals reversed a U.S. Di...lowed to pursue all of its claims against The Lash...t for trial. CTI filed a complaint against The La...onsultant for CTI,s product TRISENOX, in 2007 seek...
(Date:11/19/2009)...wire-FirstCall/ -- Omeros Corporation (Nasdaq: OM...or the third quarter ended September 30, 2009. For... reported a net loss of $3.9 million, or $1.34 per... or $2.54 per share, for the same period in 2008. ...Company reported a net loss of $15.5 million, or $...
(Date:11/19/2009)...THAM, Mass., Nov. 19 Arlington Med...hat the leading driver of antibiotic selection in ...ctivity against gram-positive and gram-negative pa...cause nosocomial pneumonia, surveyed European phys...that provide appropriate coverage against common p...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
.../ -- Biostar Pharmaceuticals,Inc. ("Biostar" or th...rted,financial results for the three months ended ... of $7,447,664 for the quarter ended March 31,2009...r of 2008. Net Income,for the first quarter 2009 w...ed basis, versus $1,821,130, or $0.08 per share, r...
...e II Study Evaluating Bavituximab in Advanced Brea...Data from Phase I Study Evaluating Bavituximab in ... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM)...oping monoclonal antibodies for the treatment of c... that data from two ongoing clinical trials assess...
...y and Manage Quality at New LIFE Nutrition Factory...eywell (NYSE: HON ) today announced that it has ...cturer of healthcare products, to provide process ...uce clinical nutrition and infusion therapy soluti...trition plant, now under construction in Melsungen...
Other Biology Technology:Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 2Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 3Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 4Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 5Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 6Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 2Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 3Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 4Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 2Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 3Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 4
...virus (CMV) pp65 Antigenemia Immunofluorescence As...cation of lower matrix protein pp65 of CMV in isol... Erythrocyte Lysis Buffer - (Catalog No. 5122)... chloride. (NH4CL) Fixation Solution (5X) - (Cata...
CultureWell multislip cell culture system MSI-12 *plate and insert fifteen 12 mm coverslips per insert* *set of 10* from Molecular Probes (Invitrogen)
Rabbit Anti-Human NCBP1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: